• Member News

Accelerate@Babraham Start-up Competition: Winners Announced

Five science start-ups have been awarded £20k and access to the Babraham Research Campus bio-incubator facilities, Accelerate@Babraham

Positive Top Line Data from the CARE CF 1 Clinical Study of Oral Lynovex in Cystic Fibrosis Exacerbations

NovaBiotics, the clinical stage biotechnology company focused on the design and development of first-in-class anti-infectives for difficult-to-treat, medically unmet diseases, this morning announces its oral therapy for cystic fibrosis, Lynovex®, has met the study objectives of the CARE CF 1 clinical trial.

Minister of State Sam Gyimah MP to open Schrödinger Building at The Oxford Science Park

Oxford, UK, July 5 2018 - The state-of-the-art Schrödinger Building at The Oxford Science Park, one of the UK's leading parks for science and technology companies, is to be opened this afternoon by Sam Gyimah MP, Minister of State for Universities, Science, Research & Innovation.

Arecor successfully defends a key Europan Polysaccharide Vaccine Patent in its opposition proceedings

Cambridge, UK., 3rd July 2018: Arecor Ltd (“the Company”), the UK-based leading formulation technology company, focussed on developing superior biopharmaceuticals and vaccines via its innovative formulation technology, continues to add to its strong patent portfolio protecting the Company’s proprietary Arestat™ technology and product assets.

Evonetix awarded Innovate UK funding for £1.3 million ($1.75M) gene synthesis project

EVONETIX LTD announced today that it had been awarded substantial funding to support the development of a novel enzymatic approach to DNA synthesis. Innovate UK, the UK’s innovation agency, will co-fund the £1.3 million project, which will be undertaken in collaboration with Durham University.

Darren Beckinsale joins The RSA Group as Consultant

The RSA Group, a leading Life Sciences executive search firm, announced today that Darren Beckinsale has joined the firm as a Consultant. Darren will form part of the firm’s fast-growing Interims Practice.

David Venables wins the Disruptor category of EY Entrepreneur Of The Year 2018, Scotland

Synpromics, the leader in gene control, is delighted to announce that David Venables, CEO of the Company, has won the ‘Disruptor’ category of Scotland’s EY Entrepreneur Of The Year 2018.

ARECOR ANNOUNCES SUPERFAST INSULIN DATA PRESENTATIONS

ARECOR ANNOUNCES SUPERFAST INSULIN DATA PRESENTATIONS AT THE AMERICAN DIABETES ASSOCIATION 78TH SCIENTIFIC SESSIONS

US$1.3 MILLION* GRANT AWARDED TO ARECOR & MANCHESTER INSTITUTE OF BIOTECHNOLOGY FROM INNOVATE UK

“Grant to significantly advance Arecor’s proprietary co-formulation platform in the development of diabetes therapies that meet critical patient unmet needs”

Adaptix Imaging is winner of The Oxford Science Park Innovation Award 2018

Oxford, UK, June 20 2018 - Adaptix Imaging’s progress in developing a new generation of low radiation dose affordable medical scanners has been recognised at the 2018 Oxfordshire Business Awards, where it has won The Oxford Science Park Innovation Award.